ASC Therapeutics and Professor Steven W. Pipe Publish
Expert Review on Novel Gene Therapies of Hemophilia A
Second-generation gene therapies can increase protein synthesis and secretion Minimizing cellular stress can increase durability of liver-targeted gene therapies A peer-reviewed, open-access, comprehensive seminal review MILPITAS, Calif.–(BUSINESS WIRE)–ASC Therapeutics, a privately held biopharmaceutical company pioneering the development of transformative in-vivo gene replacement, gene editing and allogeneic cell therapies for hematologic, metabolic and other rare diseases … Read more